Clinical Trials Logo

Depressive Disorder, Major clinical trials

View clinical trials related to Depressive Disorder, Major.

Filter by:

NCT ID: NCT00067444 Completed - Clinical trials for Depressive Disorder, Major

Depression Study In Elderly Patients

Start date: June 2003
Phase: Phase 3
Study type: Interventional

Major Depressive Disorder (MDD) Study in Elderly Outpatients

NCT ID: NCT00067301 Completed - Major Depression Clinical Trials

PUFA Augmentation in Treatment of Major Depression

Start date: September 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if omega-3 fatty acid EPA will enhance and speed up response to antidepressant therapy with Celexa (Citalopram) in people suffering from Major Depressive Disorder. All patients will receive Celexa, 50% will receive EPA, 50% placebo EPA.

NCT ID: NCT00064467 Completed - Epilepsy Clinical Trials

Lethargic Depression Study

Start date: June 2003
Phase: Phase 3
Study type: Interventional

This is a study of Major Depressive Disorder (MDD) in patients with decreased energy, pleasure and interests.

NCT ID: NCT00063206 Completed - Clinical trials for Major Depressive Disorder

Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder

Start date: n/a
Phase: Phase 3
Study type: Interventional

Primary: To compare the antidepressant efficacy and safety of subjects receiving DVS-233 SR versus subjects receiving placebo. Secondary: To assess the response of subjects receiving DVS-233 SR for the clinical global evaluation, functionality, general well-being, pain, and remission (Hamilton Psychiatric Rating Scale for Depression, 17-item [HAM-D<sub>17</sub>] < 7) versus those subjects receiving placebo.

NCT ID: NCT00062673 Completed - Depression Clinical Trials

Study of Duloxetine in Elderly Patients With Major Depressive Disorder

Start date: March 2003
Phase: Phase 3
Study type: Interventional

A study of the safety and efficacy of duloxetine in elderly patients (greater than 65 years old) with major depressive disorder

NCT ID: NCT00059579 Completed - Clinical trials for Major Depressive Disorder

Brain Regulation of Emotions in People With Depression and Anhedonia

Start date: April 24, 2003
Phase: N/A
Study type: Observational

This study will use magnetic resonance imaging (MRI) to examine how the brain regulates emotions in healthy people and in patients who have major depression and anhedonia (loss of feeling of pleasure in things that normally give pleasure). Healthy normal volunteers and patients between 18 and 50 years of age with major depression, with or without significant anhedonia, are eligible for this study. Candidates will be screened with a psychiatric interview, a physical examination that will include blood and urine samples, and an electrocardiogram, and a questionnaire about their emotions. Participants will perform a monetary reward task while lying in an MRI scanner. The task is similar to playing a computer video game with the possibility of winning cash. The amount of cash is largely dependent on the subject's performance. The accumulated amount of cash earned in a session will fluctuate depending on the subject's continuing performance level. That is, during a single session, a subject could lose money earned early in the session if his or her performance later in the session is not as good as earlier. MRI pictures will be taken during performance of the task. MRI uses a magnetic field and radio waves to produce images of body tissues and organs. The patient lies on a table that is moved into the scanner (a narrow cylinder) and wears earplugs to muffle loud knocking and thumping sounds that occur during the scanning process. The procedure will last about 1 to 1-1/2 hours.

NCT ID: NCT00057239 Completed - Clinical trials for Major Depressive Disorder (MDD)

An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder

Start date: March 2003
Phase: Phase 2
Study type: Interventional

A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Radafaxine in Patients with Major Depressive Disorder (MDD)

NCT ID: NCT00057226 Completed - Clinical trials for Depressive Disorder, Major

An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder

Start date: March 2003
Phase: Phase 2
Study type: Interventional

A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Medication in Patients with Major Depressive Disorder (MDD)

NCT ID: NCT00057213 Completed - Clinical trials for Depressive Disorder, Major

An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder

Start date: March 2003
Phase: Phase 2
Study type: Interventional

A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Medication in Patients with Major Depressive Disorder (MDD)

NCT ID: NCT00056472 Completed - Clinical trials for Major Depressive Disorder With Psychotic Features

Study of Pharmacotherapy of Psychotic Depression

STOP-PD
Start date: January 2003
Phase: Phase 3
Study type: Interventional

This study will determine the effectiveness of combining selective serotonin reuptake inhibitors (SSRIs) with antipsychotic medications in the treatment of psychotic depression.